Questions? Feedback? powered by Olark live chat software
Common Antidepressant Increased Coronary Atherosclerosis  in Animal Model

Preclinical News

Common Antidepressant Increased Coronary Atherosclerosis in Animal Model

A commonly prescribed antidepressant caused up to a six-fold increase in atherosclerosis plaque in the coronary arteries of non-human primates, according to a study by researchers at Wake Forest Baptist Medical Center. Coronary artery atherosclerosis is the primary cause of heart attacks. The study is published in the current online issue of the journal Psychosomatic continue reading



A New Way to Fight Cancer? It May Be in Our DNA.

Precision Medicine Program Launched at Comprehensive Cancer Center WINSTON-SALEM, N.C. – Feb. 10, 2015 – After a year in development, Wake Forest Baptist Medical Center today announced a new Precision Medicine program at its National Cancer Institute-designated Comprehensive Cancer Center. Precision medicine was introduced to the nation during President Obama’s State of the Union address in January. He continue reading



Study on Preclinical Study Outcomes Points to Validity Threats

Research into preclinical study outcomes published this month blames the poor success rate of medical interventions introduced into clinical development largely on flaws in preclinical research. Only 11 percent of agents that enter clinical testing are ultimately licensed, a failure rate that translates to higher drug prices and potential harm to human trial participants. The continue reading

Meet Preclinical Translational Services at Bio 2013

Preclinical Translational Services a is excited to attend the upcoming BIO International Convention April 22 to 25 at McCormick Place in Chicago. This global event for biotechnology brings together scientists, inventors and business professionals from 65 countries around the world to learn about emerging bioscience technologies and innovations, market trends and potential collaborations and opportunities. continue reading

Wake Forest Innovations sponsors and contributes at world’s largest virtual laboratory animal science conference

Wake Forest Innovations and its Preclinical Translational Services group had the distinction of being the major supporter for the world’s largest virtual laboratory animal science conference, BioConference Live, on Feb. 13-14. The conference, focused on animal welfare, had more than 12,000 attendees from a variety of backgrounds (veterinarians, technicians, and scientists) and from locations across continue reading